Tim Wilsdon and Ryan Lawlor are panelist during the session titled “Vaccines funding in Europe: Ensuring sustainability in a post-pandemic world.”
For more information on this event, click here.
Life sciences considerations for investment treaty disputes
Greg Bell, Andrew Tepperman, and Justin Ho co-authored a chapter in the ninth edition of The Investment Treaty Arbitration Review. The chapter titled...